Baylor Breast Center

Houston, Texas 77030

0 studies enrolling now · 11 studies all time

What they study most

BREAST CANCER, Breast Cancer, Estrogen Receptor Negative, Estrogen Receptor Negative Breast Cancer, Estrogen Receptor Positive, HER2/Neu Negative, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Nausea, Progesterone Receptor Negative, Progesterone Receptor Positive, Recurrent Breast Cancer, Stage IV Breast Cancer

Studies at this site

• Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer — Stopped early
• Neoadjuvant GW572016 to Treat Breast Cancer — Completed
• Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients — Completed
• Nexium Study To Suppress Nausea During Chemotherapy — Stopped early
• Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients — Stopped early
• GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer — Stopped early
• Neoadjuvant Herceptin in Patients With Breast Cancer — Stopped early
• Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer — Stopped early
• Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer — Stopped early
• Biologic Correlative Taxotere/AC — Completed
• Neoadjuvant Taxotere — Completed